Dana Investment Advisors, Inc.

Position in PAHC — Phibro Animal Health Corp

CIK 1427514 BROOKFIELD, WI

Back to PAHC Full portfolio

Position in PAHC

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$12,179,023

-$3,734,991 QoQ

Shares Held

387,867

+34.8% QoQ

Ownership

0.955%

of shares outstanding

% of Portfolio

0.34%

of 13F equity value

Holder Rank

#13

of 207 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 61% Shared 0% None 39%

Common Shares in PAHC Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Dana Investment Advisors, Inc. holds $41,564,859 across 6 Drug Manufacturers - Specialty & Generic names. PAHC ranks #1 (29.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PAHC	Phibro Animal Health Corp This page	387,867	$12,179,023
2	ANIP	Ani Pharmaceuticals Inc	109,942	$9,100,998
3	ELAN	Elanco Animal Health Inc	310,768	$7,648,000
4	NBIX	Neurocrine Biosciences Inc	36,763	$6,196,036
5	PBH	Prestige Consumer Healthcare Inc.	93,032	$4,397,622
6	ALKS	Alkermes plc.	38,992	$2,043,180

All Filings in PAHC

Export CSV

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$12,179,023	387,867	+34.8%	Shares	Sole	2026-08-13
2026-03-31	$15,914,014	287,724	-12.5%	Shares	Sole	2026-05-14
2025-12-31	$12,279,335	328,676	-7.4%	Shares	Sole	2026-02-05
2025-09-30	$14,366,739	355,085	-9.6%	Shares	Sole	2025-11-10
2025-06-30	$10,034,129	392,879	-1.5%	Shares	Sole	2025-08-13
2025-03-31	$8,522,746	399,005	-2.5%	Shares	Sole	2025-05-15
2024-12-31	$8,595,111	409,291	-11.0%	Shares	Sole	2025-02-06
2024-09-30	$10,355,213	459,823	-10.5%	Shares	Sole	2024-11-13
2024-06-30	$8,618,539	513,926	+17.2%	Shares	Sole	2024-08-27
2024-03-31	$5,668,253	438,380	—	Shares	Sole	2024-05-15
No filing history on record for this holder in this stock.